Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
Kim JS, Kim MA, Kim TM, Lee SH, Kim DW, Im SA, Kim TY, Kim WH, Yang HK, Heo DS, Bang YJ, Lee KU, Choe KJ, Kim NK. Kim JS, et al. Among authors: kim wh, kim dw, kim ma, kim ty, kim tm, kim nk. Br J Cancer. 2009 Mar 10;100(5):732-8. doi: 10.1038/sj.bjc.6604936. Br J Cancer. 2009. PMID: 19259093 Free PMC article.
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer.
Kim DW, Min HS, Lee KH, Kim YJ, Oh DY, Jeon YK, Lee SH, Im SA, Chung DH, Kim YT, Kim TY, Bang YJ, Sung SW, Kim JH, Heo DS. Kim DW, et al. Among authors: kim yj, kim ty, kim yt, kim jh. Br J Cancer. 2008 Mar 25;98(6):1118-24. doi: 10.1038/sj.bjc.6604256. Epub 2008 Feb 19. Br J Cancer. 2008. PMID: 18283317 Free PMC article.
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.
Kim DW, Kim SY, Kim HK, Kim SW, Shin SW, Kim JS, Park K, Lee MY, Heo DS. Kim DW, et al. Among authors: kim hk, kim sw, kim sy, kim js. Ann Oncol. 2007 Dec;18(12):2009-14. doi: 10.1093/annonc/mdm374. Epub 2007 Sep 4. Ann Oncol. 2007. PMID: 17785767 Free article. Clinical Trial.
Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study.
Lee JK, Shin JY, Kim S, Lee S, Park C, Kim JY, Koh Y, Keam B, Min HS, Kim TM, Jeon YK, Kim DW, Chung DH, Heo DS, Lee SH, Kim JI. Lee JK, et al. Among authors: kim jy, kim ji, kim dw, kim s, kim tm. Ann Oncol. 2013 Aug;24(8):2080-7. doi: 10.1093/annonc/mdt127. Epub 2013 Apr 4. Ann Oncol. 2013. PMID: 23559152 Free article.
5,315 results